Advertisement

Latest COVID-19 vaccine update: Pune-based Serum Institute gets DCGI nod for clinical trials of Oxford vaccine

03:16 PM Aug 03, 2020 | IANS

The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India.

The SII received approval by India's top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.

Advertisement
Advertisement

In a statement, the Health Ministry said, "Drugs Controller General of India has given approval to Serum Institute of India, Pune to conduct Phase II III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India."

Advertisement

The institute had submitted an application seeking permission for conducting the trial in July last week.

The vaccine candidate is in the midst of Phase II and III clinical trials in the UK, Phase III trials in Brazil, and Phase I and II clinical trials in South Africa

Adar Poonwalla's big risk: If Oxford vaccine Covishield dwindles, Serum Institute may lose whopping Rs 1,492 crore

( To view our epaper please Tap here . For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Advertisement